Illness	Number of cases
Pneumonia organism unspecified - Bronchopneumonia unspecified organism (J18.0)	137
Heart failure (I50.01)	122
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	90
Pneumonia organism unspecified - Pneumonia unspecified organism (J18.9)	88
Essential primary hypertension (I10.01)	81
Syncope and collapse (R55)	63
Left ventricular failure unspecified (I50.14)	62
Volume depletion (E86)	58
Essential primary hypertension (I10.91)	57
Left ventricular failure unspecified (I50.13)	50

Top 10 treatments

Treatment	Number
(9-984.8)	414
(9-984.7)	408
Computed tomography (CT) of the head without contrast medium (3-200)	338
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	335
Computed tomography of the chest with contrast medium (3-222)	221
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	209
(9-984.9)	184
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	137
Complex differential diagnostic sonography of the vascular system with quantitative evaluation (3-035)	133
Computed tomography of the abdomen with contrast medium (3-225)	125

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ31

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
25	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
4	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
1	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility